OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 17 of the 34 sources its claims cite were checked for support.
Abstract
OASIS-3 is a compilation of MRI and PET imaging and related clinical data for 1098 participants who were collected across several ongoing studies in the Washington University Knight Alzheimer Disease Research Center over the course of 15 years. Participants include 605 cognitively normal adults and 493 individuals at various stages of cognitive decline ranging in age from 42 to 95 years. The OASIS-3 dataset contains over 2000 MR sessions, including multiple structural and functional sequences. PET metabolic and amyloid imaging includes over 1500 raw imaging scans and the accompanying post-processed files from the PET Unified Pipeline (PUP) are also available in OASIS-3. OASIS-3 also contains post-processed imaging data such as volumetric segmentations and PET analyses. Imaging data is accompanied by dementia and APOE status and longitudinal clinical and cognitive outcomes. OASIS-3 is available as an open access data set to the scientific community to answer questions related to healthy aging and dementia.
Overview
CoChat Summary
TL;DR
OASIS-3 is an open-access compilation of longitudinal MRI, PET, clinical, and cognitive data from 1098 participants collected over 15 years at the Washington University Knight ADRC, spanning cognitively normal aging and early-stage Alzheimer disease. The paper describes the dataset's contents, processing pipelines (FreeSurfer, PUP, Centiloid), and exploratory analyses demonstrating feasibility of volumetric and amyloid analyses.
Key findings
- The release includes 1098 participants aged 42.5–95.6 years: 605 cognitively normal adults and 493 at various stages of cognitive decline; 850 entered with CDR 0 (605 remained normal, 245 converted), and 248 entered with CDR > 0. The APOE ε4 allele was present in 439 participants.
- Imaging inventory: 2168 MR sessions (236 at 1.5T, 1932 at 3T) and 1608 PET sessions (999 PiB, 492 Florbetapir/AV45, 117 FDG); 1912 FreeSurfer segmentations passed QC, and PUP post-processing was included for 1356 PET sessions.
- Exploratory analyses showed a significant baseline whole-brain volume group difference (F(2,974) = 32.36, p < 0.001), with greater annual atrophy in those entering with dementia (−2.01%/year, SD = 2.15) and converters (−1.68%/year, SD = 1.91) versus stable controls (−1.13%/year, SD = 1.49).
- Baseline amyloid differed significantly across groups (F(2,724) = 191.39, p < 0.001), but rate of amyloid deposition did not differ (F(2,330) = 0.19, p > 0.05); baseline amyloid correlated with later conversion while baseline whole-brain volume did not.
Methods
- Design: data descriptor compiling participants from several ongoing Knight ADRC studies (Memory and Aging Project, Adult Children Study, Healthy Aging and Senile Dementia) recruited over 15 years, with clinical/cognitive assessments standardized via the Uniform Data Set (UDS) and dementia staged by CDR.
- Data: structural and functional MRI (T1w, T2w, FLAIR, DTI, BOLD, ASL, SWI, TOF, fieldmaps), amyloid (PiB, AV45) and metabolic (FDG) PET, APOE genotyping, and longitudinal clinical/cognitive outcomes; images converted to NIfTI/BIDS and de-identified.
- Analysis: MRI processed with FreeSurfer for volumetric segmentation; PET processed with the PET Unified Pipeline (PUP) including partial volume correction and Centiloid standardization; exploratory group comparisons (stable controls, converters, dementia at entry) used ANOVA and t-tests on whole-brain volume and amyloid measures.
Limitations
- Stated: a standardized visit structure was not maintained across data collection, so investigators must use "days from entry" or "age at visit" to link imaging and clinical visits, and no association between visits was imposed; there is no categorical variable indicating healthy versus Alzheimer Disease status.
- Stated: the published OASIS datasets (Cross-sectional, Longitudinal, OASIS-3) contain overlapping participant data and should never be combined or aggregated, and links across datasets cannot be provided.
- Evident from the text: the exploratory analyses are described by the authors as "cursory" and "exploratory descriptive analyses" rather than confirmatory tests, and imaging was acquired across multiple scanner models and field strengths over 10+ years.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
12 Valid · 0 Not valid · 8 Not checked · 80 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Quality control reviewed post-processing PUP output 42,43 , which includes uptake measure for FreeSurfer-based regions, was included for 1356 PET sessions.”
What the sources say
- Partly supportedcites [42] 42. Su, Y. et al. Partial volume correction in quantitative amyloid imaging. NeuroImage 107 , 55-64 (2015). sourceExperimental — accuracy not yet measured
The Image Analysis section (page unavailable) describes quality assurance of FreeSurfer segmentation and PET uptake measures for FreeSurfer-defined regions, supporting the description of the output. It does not identify that output as PUP; the 1356-session count describes the citing authors’ dataset, not a result attributed to this source. (LLM, conf=0.78)
- Supportedcites [43] 43. Su, Y. et al. Quantitative analysis of PiB-PET with FreeSurfer ROIs. PloS One 8 , e73377 (2013). source
The Software section describes a FreeSurfer-based PET quantification workflow with output data types and quality-control reports. The FreeSurfer based analysis section describes quantitative measurements from FreeSurfer-defined regions. The citation supports the description of the processing output; the 1,356-session count describes the citing study’s own data, not a result attributed to this source. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Centiloid values 53 have been provided to standardize values across amyloid tracers PiB and Florbetapir.”
What the sources say
- Partly supportedcites [53] 53. Su, Y. et al. Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. NeuroImage Clin. 19 , 406-416 (2018). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says the Centiloid scale puts measurements on a common scale to facilitate comparisons between tracers. The Methods describe Centiloid conversion for PiB measurements in GAAIN and Knight ADRC data, but the paper does not say that it provided Centiloid values for both PiB and florbetapir in OASIS-3. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“OASIS-3 is a compilation of MRI and PET imaging and related clinical data for 1098 participants who were collected across several ongoing studies in the Washington University Knight Alzheimer Disease Research Center over the course of 15 years.”
plainn = 1,098- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“OASIS-3 also contains post-processed imaging data such as volumetric segmentations and PET analyses.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The published OASIS datasets - OASIS Cross-sectional, OASIS Longitudinal, and OASIS-3 - contain overlapping participant data and should never be combined or aggregated.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
35 more claims
Create a free account to see all 100 claims and every source verdict.
- It may state two separate claims as one. 27
- Probably not a substantial claim. 45
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“we utilize cognitively normal data from the Open Access Series of Imaging Studies - 3 (OASIS3) (LaMontagne et al., 2019) and the Alzheimer's Disease Neuroimaging Initiative (ADNI) (Alzheimer's Disease Neuroimaging Initiative (ADNI), 2004) datasets, as they are free from major brain pathologies and artifacts.”
From IterMask3D: Unsupervised Anomaly Detection and Segmentation with Test-Time Iterative Mask Refinement in 3D Brain MR (2025) · cites this paper as LaMontagne et al., 2019
Experimental — accuracy not yet measured
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom, each partial η² from its F, and each ratio, mean difference or B printed with a p checked against its own confidence interval.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“t (370) = 3.02, p = 0.002”
Reported p = .002 · recomputed p = .003
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upt(370) = 3.02reported p = .002 · recomputed p = .003
“t (370) = 3.02, p = .002”
- ConsistentF(2, 974) = 32.36reported p < .001 · recomputed p < .001
“F(2,974) = 32.36, p < .001”
- Consistentt(749) = 7.98reported p < .001 · recomputed p < .001
“t (749) = 7.98, p < .001”
- Consistentt(424) = 5.77reported p < .001 · recomputed p < .001
“t (424) = 5.77, p < .001”
- Consistentt(771) = 1.54reported p = .125 · recomputed p = .124
“t (771) = 1.54, p = .125”
8 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Exploratory MRI and PET Analyses · p. 22
“Dementia at aging started in the study with CDR > 0.”
§ Exploratory MRI and PET Analyses · p. 23
“Those who entered the study with dementia (defined as CDR > 0.5) had significantly higher amyloid levels”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Data description · p. 20
“OASIS-3 includes 1608 PET imaging sessions comprised of 999 PiB, 492 Florbetapir (AV45), and 117 FDG scans (Table 4).”
§ Data description · p. 20
“| PIB | 1000 | 937 |”
Citations
Cites
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324
Cortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · cited 1×
“In the Trail Making Test participants were asked to make a trail by connecting a series of numbers (1-26) for part A and connecting a series of alternating numbers and letters (1-A-2-B) for part B.”
Self-citationFischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
The organization of the human cerebellum estimated by intrinsic functional connectivity
Buckner, R. L., Krienen, F. M., Castellanos, A., Diaz, J. C., & Yeo, B. T. T. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00339.2011 · Cited by 7,304 · cited 1×
“…development of neuroimaging tools, such as brain atlases 3,4 , tissue segmentation algorithms 5 , and de-identification tools 6 , used to create models of healthy aging 7,8 and AD timecourse 7–11 , used to answer hypothesis driven questions 12,13 , and used for educational and training purposes.”
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147 · cited 2×
“…cortical models are complete, a number of deformable procedures were performed for further data processing and analysis including surface inflation (Fischl et al., 1999a), registration to a spherical atlas which is based on individual cortical folding patterns to match cortical geometry across…”
BackgroundMethodMeasuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,818 · cited 2×
“…white matter boundary, automated topology correction 25,36 , and surface deformation following intensity gradients to optimally place the gray/white and gray/cerebrospinal fluid borders at the location where the greatest shift in intensity defines the transition to the other tissue class 23,24 .”
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806 · cited 1×
“In the Trail Making Test participants were asked to make a trail by connecting a series of numbers (1-26) for part A and connecting a series of alternating numbers and letters (1-A-2-B) for part B.”
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731 · cited 1×
“…matter and deep gray matter volumetric structures (including hippocampus, amygdala, caudate, putamen, ventricles) 26,27 intensity normalization 35 , tessellation of the gray matter white matter boundary, automated topology correction 25,36 , and surface deformation following intensity…”
Cited by
Medical image segmentation using deep learning: A survey
Wang, R., Lei, T., Cui, R., Zhang, B., Meng, H., & Nandi, A. K. (2022) · IET Image Processing · doi:10.1049/ipr2.12419 · Cited by 892
Diffusion models in medical imaging: A comprehensive survey
Kazerouni, A., Aghdam, E. K., Heidari, M., Azad, R., Fayyaz, M., Hacihaliloglu, I., & Merhof, D. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102846 · Cited by 765
Federated learning for medical image analysis: A survey
Guan, H., Yap, P.-T., Bozoki, A., & Liu, M. (2024) · Pattern Recognition · doi:10.1016/j.patcog.2024.110424 · Cited by 518
Multimodal deep learning for Alzheimer's disease dementia assessment
Qiu, S., Miller, M. I., Joshi, P. S., Lee, J. C., Xue, C., Ni, Y., Wang, Y., De Anda-Duran, I., Hwang, P. H., Cramer, J. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31037-5 · Cited by 420
Li, J., Chen, J., Tang, Y., Wang, C., Landman, B. A., & Zhou, S. K. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102762 · Cited by 389
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease
Fortea, J., Pegueroles, J., Alcolea, D., Belbin, O., Dols-Icardo, O., Vaqué-Alcázar, L., Videla, L., Gispert, J. D., Suárez-Calvet, M., Johnson, S. C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02931-w · Cited by 369
Li, Y., El Habib Daho, M., Conze, P.-H., Zeghlache, R., Le Boité, H., Tadayoni, R., Cochener, B., Lamard, M., & Quellec, G. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108635 · Cited by 274
“OASIS-3 contains 755 cognitively normal adults and 622 individuals at various stages of cognitive decline ranging in age from 42-95 years (LaMontagne et al., 2019).”
BackgroundDeep learning-based approaches for multi-omics data integration and analysis
Ballard, J. L., Wang, Z., Li, W., Shen, L., & Long, Q. (2024) · BioData Mining · doi:10.1186/s13040-024-00391-z · Cited by 258
Review of multimodal machine learning approaches in healthcare
Krones, F., Marikkar, U., Parsons, G., Szmul, A., & Mahdi, A. (2025) · Information Fusion · doi:10.1016/j.inffus.2024.102690 · Cited by 235
Celard, P., Iglesias, E. L., Sorribes-Fdez, J. M., Romero, R., Vieira, A. S., & Borrajo, L. (2023) · Neural Computing and Applications · doi:10.1007/s00521-022-07953-4 · Cited by 188
Diogo, V. S., Ferreira, H. A., Prata, D., & Initiative, F. T. A. D. N. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01047-y · Cited by 184
“OASIS From the OASIS-3 dataset of the OASIS project, 531 subjects were included (463 HD, 70 AD) [35].”
MethodA review of uncertainty estimation and its application in medical imaging
Zou, K., Chen, Z., Yuan, X., Shen, X., Wang, M., & Fu, H. (2023) · Meta-Radiology · doi:10.1016/j.metrad.2023.100003 · Cited by 158
Zhao, Z., Chuah, J. H., Lai, K. W., Chow, C., Gochoo, M., Dhanalakshmi, S., Wang, N., Bao, W., & Wu, X. (2023) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2023.1038636 · Cited by 184
“Most pervasively used datasets include Alzheimer’s Disease Neuroimaging Initiative (ADNI) (Jack et al., ) (Ellis et al., 2009), Open Access Series of Imaging Studies (OASIS) (Marcus et al., 2007, 2010; LaMontagne et al., 2019), and Minimal Interval Resonance Imaging in Alzheimer’s Disease (MIRIAD) (Malone et al., 2013…”
BackgroundInfluentialFederated learning for healthcare applications
Chaddad, A., Wu, Y., & Desrosiers, C. (2024) · IEEE Internet of Things Journal · doi:10.1109/jiot.2023.3325822 · Cited by 136
“The approach was tested on three data sets, namely, OASIS-3 [139], ADNI [83], and an internal data set (KRI), and the results showed significant improvement in anomaly segmentation when compared to locally trained models without annotations or sharing of private local data.”
MethodMRI Deep Learning-Based Solution for Alzheimer’s Disease Prediction
Saratxaga, C. L., Moya, I., Picón, A., Acosta, M., Moreno-Fernández-de-Leceta, A., Garrote, E., & Bereciartua, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090902 · Cited by 166
Explainable AI-based Alzheimer’s prediction and management using multimodal data
Jahan, S., Abu Taher, K., Kaiser, M. S., Mahmud, M., Rahman, M. S., Hosen, A. S. M. S., & Ra, I.-H. (2023) · PLOS ONE · doi:10.1371/journal.pone.0294253 · Cited by 122
Hajamohideen, F., Shaffi, N., Mahmud, M., Karthikeyan, S., Sariri, A. A., Viswan, V., Abdesselam, A., & Initiative, A. D. N. (2023) · Brain Informatics · doi:10.1186/s40708-023-00184-w · Cited by 140
“This section presents a series of experiments to corroborate Siamese architecture’s efficacy using two publicly available databases: the Open Access Series of Imaging Studies (OASIS) [11] and the Alzheimer’s Disease Neuro-imaging Initiative (ADNI) [61] dataset.”
MethodBrain-age prediction: A systematic comparison of machine learning workflows
More, S., Antonopoulos, G., Hoffstaedter, F., Caspers, J., Eickhoff, S. B., Patil, K. R., & Initiative, T. A. D. N. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.119947 · Cited by 128
CLIP in medical imaging: A survey
Zhao, Z., Liu, Y., Wu, H., Wang, M., Li, Y., Wang, S., Teng, L., Liu, D., Cui, Z., Wang, Q., et al. (2025) · Medical Image Analysis · doi:10.1016/j.media.2025.103551 · Cited by 281
Automated detection of Alzheimer’s disease: a multi-modal approach with 3D MRI and amyloid PET
Castellano, G., Esposito, A., Lella, E., Montanaro, G., & Vessio, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-56001-9 · Cited by 115
“In this study, we employed the OASIS-3 dataset 10 , the most recent iteration of the OASIS series, increasingly recognized as a benchmark for diverse research goals within the scientific community 30–33 .”
MethodChui, K. T., Gupta, B. B., Alhalabi, W., & Alzahrani, F. S. (2022) · Diagnostics · doi:10.3390/diagnostics12071531 · Cited by 122
“Datasets and Methodology The details of the three benchmark datasets OASIS-1 [8], OASIS-2 [9], and OASIS-3 [10] are firstly summarized.”
BackgroundModel optimization techniques in personalized federated learning: A survey
Sabah, F., Chen, Y., Yang, Z., Azam, M., Ahmad, N., & Sarwar, R. (2023) · Expert Systems with Applications · doi:10.1016/j.eswa.2023.122874 · Cited by 151
Beyond the average patient: how neuroimaging models can address heterogeneity in dementia
Verdi, S., Marquand, A. F., Schott, J. M., & Cole, J. H. (2021) · Brain · doi:10.1093/brain/awab165 · Cited by 106
Learning disentangled representations in the imaging domain
Liu, X., Sanchez, P., Thermos, S., O’Neil, A. Q., & Tsaftaris, S. A. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102516 · Cited by 169
Zuo, L., Dewey, B. E., Liu, Y., He, Y., Newsome, S. D., Mowry, E. M., Resnick, S. M., Prince, J. L., & Carass, A. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118569 · Cited by 125
Federated disentangled representation learning for unsupervised brain anomaly detection
Bercea, C. I., Wiestler, B., Rueckert, D., & Albarqouni, S. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00515-2 · Cited by 150
Functional Connectivity of the Brain Across Rodents and Humans
Xu, N., LaGrow, T. J., Anumba, N., Lee, A., Zhang, X., Yousefi, B., Bassil, Y., Clavijo, P. G., Sharghi, V. K., Maltbie, E. A., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.816331 · Cited by 119
Object recognition datasets and challenges: A review
Salari, A., Djavadifar, A., Liu, X., & Najjaran, H. (2022) · Neurocomputing · doi:10.1016/j.neucom.2022.01.022 · Cited by 110
A Comprehensive Review on AI-Enabled Models for Parkinson’s Disease Diagnosis
Dixit, S., Bohre, K., Singh, Y., Himeur, Y., Mansoor, W., Atalla, S., & Srinivasan, K. (2023) · Electronics · doi:10.3390/electronics12040783 · Cited by 109
Diagnosis of Alzheimer Disease Using 2D MRI Slices by Convolutional Neural Network
Al-Khuzaie, F. E. K., Bayat, O., & Duru, A. D. (2021) · Applied Bionics and Biomechanics · doi:10.1155/2021/6690539 · Cited by 89
RetractedFarid, A. A., Selim, G. I., & Khater, H. (2020) · International Journal of Scientific and Engineering Research · doi:10.14299/ijser.2020.03.02 · Cited by 100
Brain aging patterns in a large and diverse cohort of 49,482 individuals
Yang, Z., Wen, J., Erus, G., Govindarajan, S. T., Melhem, R., Mamourian, E., Cui, Y., Srinivasan, D., Abdulkadir, A., Parmpi, P., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03144-x · Cited by 112
“…in the John Hopkins University study (BIOCARD) 80 , the https://doi.org/10.1038/s41591-024-03144-x Open Access Series of Imaging Studies (OASIS) 81 , the University of Pennsylvania Memory Center cohort (PENN), the Wisconsin Registry for Alzheimer’s Prevention (WRAP) studies 82 , the Coronary…”
BackgroundInfluentialSelf-citationRallabandi, V. P. S., & Seetharaman, K. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.104312 · Cited by 102
Data synthesis and adversarial networks: A review and meta-analysis in cancer imaging
Osuala, R. O., Kushibar, K., Garrucho, L., Linardos, A., Szafranowska, Z., Klein, S., Glocker, B., Díaz, O., & Lekadir, K. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102704 · Cited by 118
Closing the life-cycle of normative modeling using federated hierarchical Bayesian regression
Kia, S. M., Huijsdens, H., Rutherford, S. E., de Boer, A. A. A., Dinga, R., Wolfers, T., Berthet, P., Mennes, M., Andreassen, O. A., Westlye, L. T., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278776 · Cited by 106
DiffuseMorph: Unsupervised Deformable Image Registration Using Diffusion Model
Kim, B., Han, I., & Ye, J. C. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-19821-2_20 · Cited by 171
“Also, we used OASIS-3 dataset [27] for 3D brain MR registration.”
MethodConditional GAN with 3D discriminator for MRI generation of Alzheimer’s disease progression
Jung, E., Luna, M., & Park, S. H. (2022) · Pattern Recognition · doi:10.1016/j.patcog.2022.109061 · Cited by 97
A hitchhiker’s guide to working with large, open-source neuroimaging datasets
Horien, C. L., Noble, S., Greene, A. S., Lee, K., Barron, D. S., Gao, S., O’Connor, D. A., Salehi, M., Dadashkarimi, J., Shen, X., et al. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-01005-4 · Cited by 79
Tatekawa, H., Matsushita, S., Ueda, D., Takita, H., Horiuchi, D., Atsukawa, N., Morishita, Y., Tsukamoto, T., Shimono, T., & Miki, Y. (2022) · Japanese Journal of Radiology · doi:10.1007/s11604-022-01370-2 · Cited by 78
Chen, Z., Liu, Y., Zhang, Y., & Li, Q. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102698 · Cited by 75
“To further validate the generalization performance of OLFG, we also conduct performance evaluation on an independent external cohort, i.e., the OASIS-3 dataset (LaMontagne et al., 2019), containing 29 AD patients and 329 normal controls.”
Explainable Artificial Intelligence in Neuroimaging of Alzheimer’s Disease
Taiyeb Khosroshahi, M., Morsali, S., Gharakhanlou, S., Motamedi, A., Hassanbaghlou, S., Vahedi, H., Pedrammehr, S., Kabir, H. M. D., & Jafarizadeh, A. (2025) · Diagnostics · doi:10.3390/diagnostics15050612 · Cited by 68
“OASIS-3 features data from 1378 participants with 2842 MR sessions (including T1w, T2w, FLAIR, SWI, resting-state BOLD, and DTI sequences) and 2157 raw PET scans, along with cognitive assessments from the Uniform Data Set (UDS) [133].”
Iraji, A., Fu, Z., Faghiri, A., Duda, M., Chen, J., Rachakonda, S., DeRamus, T. P., Kochunov, P., Adhikari, B. M., Belger, A., et al. (2023) · Human Brain Mapping · doi:10.1002/hbm.26472 · Cited by 98
Sendi, M. S. E., Zendehrouh, E., Miller, R. L., Fu, Z., Du, Y., Liu, J., Mormino, E. C., Salat, D. H., & Calhoun, V. D. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.593263 · Cited by 68
ImUnity: A generalizable VAE-GAN solution for multicenter MR image harmonization
Cackowski, S., Barbier, E., Dojat, M., & Christen, T. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102799 · Cited by 86
Transfer Learning Approaches for Neuroimaging Analysis: A Scoping Review
Ardalan, Z., & Subbian, V. (2022) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2022.780405 · Cited by 78
“For the target domain, 22 different datasets were utilized with ADNI, OpenAccessible Summaries In Language Studies (OASIS) (LaMontagne et al., 2019), and Human Connectome Project (HCP) being the most frequently used datasets (ADNI 26, OASIS 3, and HCP 3 times, respectively).”
MethodA systematic collection of medical image datasets for deep learning
Li, J., Zhu, G., Hua, C., Feng, M., BasheerBennamoun, Li, P., Lu, X., Song, J., Shen, P., Xu, X., et al. (2021) · arXiv · doi:10.48550/arxiv.2106.12864 · Cited by 61
Hierarchical Bayesian Regression for Multi-site Normative Modeling of Neuroimaging Data
Kia, S. M., Huijsdens, H., Dinga, R., Wolfers, T., Mennes, M., Andreassen, O. A., Westlye, L. T., Beckmann, C. F., & Marquand, A. F. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-59728-3_68 · Cited by 77
Koenig, L. N., Day, G. S., Salter, A. R., Keefe, S., Marple, L. M., Long, J. M., LaMontagne, P., Massoumzadeh, P., Snider, B. J., Kanthamneni, M., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102248 · Cited by 70
Self-citationAge-level bias correction in brain age prediction
Zhang, B., Zhang, S., Feng, J., & Zhang, S. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103319 · Cited by 67
Liu, M., Zhang, H., Shi, F., & Shen, D. G. (2023) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2023.3282961 · Cited by 75
“…three datasets: 1) AD neuroimaging initiative (ADNI-2 and ADNI-GO; http://adni. loni.usc.edu/) [31]; 2) open-access series of imaging studies (OASIS-3; https://www.oasis-brains.org/) [32]; and 3) autism brain imaging data exchange (ABIDE-I; https://fcon_1000. projects.nitrc.org/indi/abide/) [33].”
BackgroundSingh, S. G., Das, D., Barman, U., & Saikia, M. J. (2024) · Diagnostics · doi:10.3390/diagnostics14161759 · Cited by 69
“Future expansions with more diverse participants and additional biomarker data could address these limitations and enhance its utility for Alzheimer’s research [17].”
BackgroundSun, Y., Wang, L., Li, G., Lin, W., & Wang, L. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01283-7 · Cited by 113
“https://doi.org/10.1038/s41551-024-01283-7 data.healthybrainnetwork.org/main.php), HCP 56 (http://www.human-connectomeproject.org/data), ICBM 89 (https://ida.loni.usc.edu/home/ projectPage.jsp?project=ICBM), OASIS3 57 (https://sites.wustl.edu/ oasisbrains/), SLIM 90 (https://fcon_1000.projects.nitrc.org/indi/retro/ so…”
InfluentialAI-driven fusion of multimodal data for Alzheimer’s disease biomarker assessment
Jasodanand, V. H., Kowshik, S. S., Puducheri, S., Romano, M. F., Xu, L., Au, R., & Kolachalama, V. B. (2025) · Nature Communications · doi:10.1038/s41467-025-62590-4 · Cited by 94
“These data sources were aggregated from seven independent cohorts: NACC,A4,OASIS3,AIBL,FHS,ADNIandHABS.”
InfluentialYang, Z., Wen, J., Abdulkadir, A., Cui, Y., Erus, G., Mamourian, E., Melhem, R., Srinivasan, D., Govindarajan, S. T., Chen, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44271-2 · Cited by 61
“…Imaging, Biomarker, and Lifestyle study of aging (AIBL) 69 , the Biomarkers of Cognitive Decline Among Normal Individuals in the Johns Hopkins (BIOCARD) 70 , the Open Access Series of Imaging Studies (OASIS) 71 , PENN, and the Wisconsin Registry for Alzheimer ’ s Prevention (WRAP) studies 72 .”
Self-citationSendi, M. S. E., Zendehrouh, E., Fu, Z., Liu, J., Du, Y., Mormino, E. C., Salat, D. H., Calhoun, V. D., & Miller, R. L. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0847 · Cited by 54
“In this work, from longitudinal rs-fMRI data (LaMontagne et al., 2019), we predicted that CCN dFC in AD and its correlation with behavioral scores could elucidate the pathophysiological mechanism of this neurological disorder.”
InfluentialRavì, D., Blumberg, S. B., Ingala, S., Barkhof, F., Alexander, D. C., & Oxtoby, N. P. (2021) · Medical Image Analysis · doi:10.1016/j.media.2021.102257 · Cited by 80
“To demonstrate this point, we have considered a second dataset called OASIS-3 ( LaMontagne et al., 2019 ) where we selected all the subjects diagnosed as CN or AD, aged in the range between 60–85 and having at least one follow-up 3 years after the baseline scan.”
InfluentialMachine learning, artificial intelligence and the prediction of dementia
Merkin, A., Krishnamurthi, R., & Medvedev, O. N. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000768 · Cited by 63
HACA3: A unified approach for multi-site MR image harmonization
Zuo, L., Liu, Y., Xue, Y., Dewey, B. E., Remedios, S. W., Hays, S. P., Bilgel, M., Mowry, E. M., Newsome, S. D., Calabresi, P. A., et al. (2023) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2023.102285 · Cited by 62
Bhattarai, P., Thakuri, D. S., Nie, Y., & Chand, G. B. (2024) · European Journal of Radiology · doi:10.1016/j.ejrad.2024.111403 · Cited by 66
Heterogeneous Graph Learning for Multi-Modal Medical Data Analysis
Kim, S., Lee, N., Lee, J., Hyun, D., & Park, C. (2023) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v37i4.25643 · Cited by 78
Multimodal transformer network for incomplete image generation and diagnosis of Alzheimer’s disease
Gao, X., Shi, F., Shen, D. G., & Liu, M. (2023) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2023.102303 · Cited by 64
A Low-Cost Three-Dimensional DenseNet Neural Network for Alzheimer’s Disease Early Discovery
Solano-Rojas, B. J., & Villalón-Fonseca, R. (2021) · Sensors · doi:10.3390/s21041302 · Cited by 60
“Among the possible data sources for validation are our local health centers or Open Access Series of Imaging Studies (OASIS) [36].”
A Systematic Collection of Medical Image Datasets for Deep Learning
Li, J., Zhu, G., Hua, C., Feng, M., Bennamoun, B., Li, P., Lu, X., Song, J., Shen, P., Xu, X., et al. (2023) · ACM Computing Surveys · doi:10.1145/3615862 · Cited by 112
Designing a clinical decision support system for Alzheimer’s diagnosis on OASIS-3 data set
Salami, F., Bozorgi-Amiri, A., Hassan, G. M., Tavakkoli-Moghaddam, R. R., & Datta, A. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.103527 · Cited by 55
A Survey of Deep Learning for Alzheimer’s Disease
Zhou, Q., Wang, J., Yu, X., Wang, S., & Zhang, Y. (2023) · Machine Learning and Knowledge Extraction · doi:10.3390/make5020035 · Cited by 68
Brain structure ages—A new biomarker for multi‐disease classification
Nguyen, H., Clément, M., Mansencal, B., & Coupé, P. (2024) · Human Brain Mapping · doi:10.1002/hbm.26558 · Cited by 57
“First, eight datasets including 2887 images (i.e., ABIDE I, ADNI, AIBL, ICBM, C-MIND, IXI, NDAR, OASIS1) were used in training/validation.”
InfluentialVanBerlo, B., Hoey, J., & Wong, A. M. (2024) · BMC Medical Imaging · doi:10.1186/s12880-024-01253-0 · Cited by 76
“Several studies have utilized the ADNI [127] and OASIS-3 [128] datasets to develop classifiers that can detect brain MRI scans of patients with Alzheimer’s disease (AD).”
MethodSubtyping of mild cognitive impairment using a deep learning model based on brain atrophy patterns
Kwak, K., Giovanello, K. S., Bozoki, A., Styner, M., & Dayan, E. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100467 · Cited by 47
Decentralized Learning in Healthcare: A Review of Emerging Techniques
Shiranthika, C., Saeedi, P., & Bajić, I. V. (2023) · IEEE Access · doi:10.1109/access.2023.3281832 · Cited by 71
“Series of Imaging Studies-3 (OASIS-3) [61] and Alzheimer’s”
BackgroundPreclinical Stage Alzheimer's Disease Detection Using Magnetic Resonance Image Scans
Altay, F., Sánchez, G. R., Zhang‐James, Y., Faraone, S. V., Velipasalar, S., & Salekin, A. (2021) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v35i17.17772 · Cited by 63
“In this work, we employ the recently published longitudinal neuroimaging, clinical and cognitive dataset, called OASIS3 (LaMontagne et al. 2019).”
MethodPombo, G., Gray, R., Cardoso, M. J., Ourselin, S., Rees, G. E., Ashburner, J., & Nachev, P. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102723 · Cited by 76
“Brain imaging is often replicated across multiple acquisition types (Miller et al., 2016; LaMontagne et al., 2019; Petersen et al., 2010), time periods, and stages of disease progression (LaMontagne et al., 2019; Petersen et al., 2010).”
InfluentialDeep learning for the harmonization of structural MRI scans: a survey
Abbasi, S., Lan, H., Choupan, J., Sheikh‐Bahaei, N., Pandey, G. S., & Varghese, B. A. (2024) · BioMedical Engineering OnLine · doi:10.1186/s12938-024-01280-6 · Cited by 69
Age‐related decrements in cortical gyrification: Evidence from an accelerated longitudinal dataset
Madan, C. R. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15039 · Cited by 50
“Dataset Data from 280 healthy adults (aged 45-92) from the OASIS-3 (Open Access Series of Imaging Studies 3) dataset (LaMontagne et al., 2019) were included in the analyses presented here.”
MethodVessel-CAPTCHA: An efficient learning framework for vessel annotation and segmentation
Dang, V. N., Galati, F., Cortese, R., Giacomo, G. D., Marconetto, V., Mathur, P., Lekadir, K., Lorenzi, M., Prados, F., & Zuluaga, M. A. (2021) · Medical Image Analysis · doi:10.1016/j.media.2021.102263 · Cited by 59
Perez‐Valero, E., López-Gordo, M. A., Morillas, C. A., Pelayo, F. J., & Vaquero‐Blasco, M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201455 · Cited by 48
Review of Federated Learning and Machine Learning-Based Methods for Medical Image Analysis
Hernandez-Cruz, N., Saha, P., Sarker, M. M. K., & Noble, J. A. (2024) · Big Data and Cognitive Computing · doi:10.3390/bdcc8090099 · Cited by 65
“FedCM evaluated its performance on the ADNI [111] and OASIS [82] datasets, achieving accuracy rates of 74.5%, 76.0%, and 76.0% for a three-class classification task.”
InfluentialScan Once, Analyse Many: Using Large Open-Access Neuroimaging Datasets to Understand the Brain
Madan, C. R. (2021) · Neuroinformatics · doi:10.1007/s12021-021-09519-6 · Cited by 50
Data-Free Knowledge Distillation via Feature Exchange and Activation Region Constraint
Yu, S., Chen, J., Han, H., & Jiang, S. (2023) · IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings - IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings · doi:10.1109/cvpr52729.2023.02324 · Cited by 76
“, due to privacy issues in medical data [1, 2, 5, 20, 28, 35] and portrait data [3], and copyright and privateness of large data volume such as JFT-300M [40] and text-image data [37].”
BackgroundCan Segmentation Models Be Trained with Fully Synthetically Generated Data?
Fernández, V., Pinaya, W. H. L., Borges, P., Tudosiu, P.-D., Graham, M. S., Vercauteren, T. K., & Cardoso, M. J. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-16980-9_8 · Cited by 91
Classification of Alzheimer’s disease stages from magnetic resonance images using deep learning
Mora-Rubio, A., Bravo-Ortíz, M. A., Arredondo, S., Saborit-Torres, J. M., Ruz, G. A., & Tabares-Soto, R. (2023) · PeerJ Computer Science · doi:10.7717/peerj-cs.1490 · Cited by 52
A comprehensive review on transformer network for natural and medical image analysis
Thirunavukarasu, R., & Kotei, E. (2024) · Computer Science Review · doi:10.1016/j.cosrev.2024.100648 · Cited by 50
Thyreau, B., & Taki, Y. (2020) · Medical Image Analysis · doi:10.1016/j.media.2020.101639 · Cited by 40
Joo, Y., Namgung, E., Jeong, H. S., Kang, I., Kim, J., Oh, S., Lyoo, I. K., Yoon, S. J., & Hwang, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-49514-2 · Cited by 58
One model to unite them all: Personalized federated learning of multi-contrast MRI synthesis
Dalmaz, O., Mirza, M. U., Elmas, G., Özbey, M., Dar, S. U. H., Ceyani, E., Oğuz, K. K., Avestimehr, S., & Çukur, T. (2024) · Medical Image Analysis · doi:10.1016/j.media.2024.103121 · Cited by 87
Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease
Pan, D., Zeng, A., Yang, B., Lai, G., Hu, B., Song, X., Jiang, T., & Initiative, A. D. N. (2022) · Advanced Science · doi:10.1002/advs.202204717 · Cited by 42
Explainable AI for Alzheimer Detection: A Review of Current Methods and Applications
Saif, F. H., Al-Andoli, M. N., & Bejuri, W. M. Y. W. (2024) · Applied Sciences · doi:10.3390/app142210121 · Cited by 53
Adaptive 3DCNN-Based Interpretable Ensemble Model for Early Diagnosis of Alzheimer’s Disease
Pan, D., Luo, G., Zeng, A., Zou, C., Liang, H., Wang, J., Zhang, T., & Yang, B. (2022) · IEEE Transactions on Computational Social Systems · doi:10.1109/tcss.2022.3223999 · Cited by 47
“Moreover, we retrieve 196 sMRI images of 196 subjects (AD = 105 and NC = 91; Table III) from the OASIS database utilized in [21] to further conduct a multicenter research trial.”
MethodBacas, E., Kahhalé, I., Raamana, P. R., Pablo, J. B., Anand, A. S., & Hanson, J. L. (2023) · Human Brain Mapping · doi:10.1002/hbm.26292 · Cited by 43
β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3
Bourgeat, P., Doré, V., Burnham, S. C., Benzinger, T. L. S., Tosun, D., Li, S., Goyal, M. S., LaMontagne, P., Jin, L., Rowe, C. C., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119527 · Cited by 39
“Data Data used in this study combined three of the largest and publicly vailable imaging studies in AD, namely AIBL ( Ellis et al., 2009 ), ADNI Petersen et al., 2010 ) and OASIS3 ( LaMontagne et al., 2019 ).”
Self-citationFederated Multi-Site Normative Modeling using Hierarchical Bayesian RegressionPreprint
Kia, S. M., Huijsdens, H., Rutherford, S., Dinga, R., Wolfers, T., Mennes, M., Andreassen, O., Westlye, L., Beckmann, C., & Marquand, A. (2021) · bioRxiv · doi:10.1101/2021.05.28.446120 · Cited by 32
“Then, in each run 50% of random healthy participants in clinical datasets, including CNP, HCPEP, OASIS3, and TOP are used to recalibrate the parameters of the reference model.”
Machine learning prediction of tau‐PET in Alzheimer's disease using plasma, MRI, and clinical data
Karlsson, L., Vogel, J., Arvidsson, I., Åström, K., Strandberg, O., Seidlitz, J., Bethlehem, R. A. I., Stomrud, E., Ossenkoppele, R., Ashton, N. J., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.14600 · Cited by 43
Coordinate Translator for Learning Deformable Medical Image Registration
Liu, Y., Zuo, L., Han, S., Xue, Y., Prince, J. L., & Carass, A. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-18814-5_10 · Cited by 70
A survey of emerging applications of diffusion probabilistic models in MRI
Fan, Y., Liao, H., Huang, S., Luo, Y., Fu, H., & Qi, H. (2024) · Meta-Radiology · doi:10.1016/j.metrad.2024.100082 · Cited by 52
Stouffer, K. M., Chen, C., Kulason, S., Xu, E., Witter, M. P., Ceritoglu, C., Albert, M., Mori, S., Troncoso, J. C., Tward, D. J., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103374 · Cited by 37
“Such datasets include OASIS-3 (LaMontagne et al., 2019) and the developing Alz-heimer ’ s Disease Connectome Project (Van Essen and Glassers, 2016).”
Revolutionizing healthcare: a comparative insight into deep learning’s role in medical imaging
Prasad, V. K., Verma, A., Bhattacharya, P., Shah, S., Chowdhury, S., Bhavsar, M. D., Aslam, S., & Ashraf, N. (2024) · Scientific Reports · doi:10.1038/s41598-024-71358-7 · Cited by 52
“Three datasets, referred to as OASIS-1, OASIS-2, and OASIS-3 92–94 , have been made available by the OASIS project and are primarily used for research on AD.”
Signed graph representation learning for functional-to-structural brain network mapping
Tang, H., Guo, L., Fu, X., Wang, Y., Mackin, S. R., Ajilore, O., Leow, A., Thompson, P. M., Huang, H., & Zhan, L. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102674 · Cited by 42
Shaffi, N., Hajamohideen, F., Mahmud, M., Abdesselam, A., Karthikeyan, S., & Sariri, A. A. (2022) · Lecture notes in computer science · doi:10.1007/978-3-031-15037-1_23 · Cited by 34
Wilms, M., Bannister, J. J., Mouchès, P., MacDonald, M. E., Rajashekar, D., Langner, S., & Forkert, N. D. (2022) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2022.3161947 · Cited by 40
“This data set is derived from five different databases: (1) [55].”
MethodZhang, Z.-C., Zhao, X., Dong, G., & Zhao, X. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3280823 · Cited by 37
Karaman, B. K., Mormino, E. C., Sabuncu, M. R., & Initiative, A. D. N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277322 · Cited by 43
“In the realm of AD, public and private databases [6–10] serve as important resources for the application of machine learning algorithms that help characterize disease heterogeneity [11], guide therapy [12], and develop and evaluate potential treatments [13, 14].”
Metadata
- Authors
- LaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., Raichle, M. E., Cruchaga, C., & Marcus, D.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- LaMontagne, Pamela J.
- ORCID
- Venue
- medRxiv
- Publisher
- openRxiv
- Published
- 2019-12-15
- OpenAlex
- W2995808388
- Cited by
- 779
- References
- 62
- Citations by year
- 2026: 98 · 2025: 158 · 2024: 155 · 2023: 142 · 2022: 125 · 2021: 73 · 2020: 27
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nd
- Locations
- medRxiv (acceptedVersion, cc-by-nd)
- Funders
- Eli Lilly and Company
- National Institutes of Health (P30 NS09857781, UL1TR000448, P50 AG00561)
- Avid Radiopharmaceuticals
- Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis (P01AG003991)
- National Institute on Aging (R01AG043434, P01AG003991, P01AG026276)
- National Institute of Biomedical Imaging and Bioengineering (R01EB009352)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
- Keywords
- OASIS-3, Alzheimer's disease, normal aging, cognitive decline, longitudinal neuroimaging, structural MRI, functional MRI, positron emission tomography, amyloid imaging, glucose metabolism, 3D image segmentation, dementia, apolipoprotein E, cognitive outcomes, healthy aging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.